Related Experiment Video
Updated: Jun 3, 2026
11:17
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
Published on: November 25, 2025
The serotonin syndrome-the need for physician's awareness
Bhawana Arora1, Nirupama Kannikeswaran
1Department of Pediatric Emergency Medicine, Children's Hospital of Michigan, Detroit Medical Center, 3901 Beaubien Street, Detroit, MI 48201 USA.
International Journal of Emergency Medicine
|March 5, 2011
Summary
Serotonin syndrome (SS) is a dangerous drug reaction. Prompt diagnosis and supportive care, like fluids and lorazepam, lead to recovery in most cases, preventing adverse outcomes.
Area of Science:
- Pharmacology
- Clinical Toxicology
- Emergency Medicine
Background:
- Serotonin syndrome (SS) is a life-threatening adverse drug reaction.
- It commonly results from selective serotonin reuptake inhibitor (SSRI) use, overdose, or drug interactions.
Purpose of the Study:
- To present a case of serotonin syndrome in a pediatric patient.
- To highlight the importance of early diagnosis and supportive care in managing SS.
Main Methods:
- A 16-year-old male presented with altered mental status, fever, hypertension, tachycardia, and rigidity.
- Diagnosis of SS was based on fluoxetine intake history and clinical signs including clonus and agitation.
- Treatment involved supportive care with intravenous fluids and lorazepam.
Main Results:
- The patient's mental status improved within 24 hours with supportive care.
- Neurological examination normalized, and the patient was discharged for psychiatric follow-up.
Conclusions:
- Serotonin syndrome is increasingly frequent and usually resolves with prompt recognition and supportive care.
- Delayed diagnosis and underestimation of adverse drug effects can lead to poor outcomes.
Related Concept Videos
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...